Anne M. Phillips

Executive

Director

US·SEC (Form 4)

Vaccitech plcBarinthus Biotherapeutics plc.

Total declarations

Company

▲ Purchases (1 ops.)

€42k

▼ Sales (0 ops.)

—

Latest filing published 09 Sept 2026 for Barinthus Biotherapeutics plc.. Read the official filing

Filing timeline

BuySale

Anne M. Phillips

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Anne M. Phillips: trading record in brief

Anne M. Phillips (senior executive) discloses dealings in Vaccitech plc to SEC (Form 4). The record holds 2 filings, for trades running from 4 May 2021 to 9 September 2026.

No open-market sale appears; the market trades are 1 purchase worth €42k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The newest entry dates from 9 September 2026: a transaction, in Vaccitech plc. The clock since the last published purchase (6 May 2021) now reads 1,991 days. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.